Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight and modulates gut peptide release—Potential insight into mechanism of action
Lists
Only you see this
Abstract
Treatment with DGAT1 inhibitors improves lipid metabolism and body weight. DGAT1 inhibition leads to enhanced PC production via alternative carbon channeling. Immunohistological studies suggest that DGAT1 inhibitor's effects on plasma gut peptide levels are likely via an indirect mechanism. Overall these data indicate a translational potential towards the clinic.
BibTeX
@inproceedings{liu2013pharmacological,
author = {Jinqi Liu and Judith N. Gorski and Stephen J. Gold and Dunlu Chen and Shirley Chen and Gail Forrest and Yoshiki Itoh and Donald J. Marsh and David G. McLaren and Zhu Shen and Lisa M. Sonatore and Ester Carballo‐Jane and Stephanie Craw and Xiao-Ming Guan and Bindhu V. Karanam and Junichi Sakaki and Daphne Szeto and Xinchun Tong and Jianying Xiao and Ryo Yoshimoto and Hong Yu and Thomas P. Roddy and James M. Balkovec and Shirly Pinto},
title = {{Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight and modulates gut peptide release—Potential insight into mechanism of action}},
booktitle = {Obesity},
year = {2013},
doi = {10.1002/oby.20193},
}Loading related content...